SCHEMBL175567

SCHEMBL175567

CCOC(=O)c1c2ccnc1-2

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.50
CA1 P00915 1/20 0.50
CA2 P00918 1/20 0.50
CA7 P43166 1/20 0.50
CA9 Q16790 1/20 0.50
CA14 Q9ULX7 1/20 0.50
TDP2 O95551 4/20 0.48
ALDH1A1 P00352 2/20 0.46
HPGD P15428 2/20 0.46
HSD17B10 Q99714 1/20 0.46
NR1H2 P55055 1/20 0.44
NR1H3 Q13133 1/20 0.44
CYP1A2 P05177 1/20 0.44
ADORA3 P0DMS8 2/20 0.44
BRD4 O60885 1/20 0.44
NUDT1 P36639 1/20 0.44
TSHR P16473 1/20 0.44
KDM4E B2RXH2 1/20 0.44
NPC1 O15118 1/20 0.44
LMNA P02545 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31091354 0.83 ADORA3 (0.57) ALDH1A1HPGDHSD17B10CYP1A2ADORA3
SCHEMBL2113012 0.75 CA12 (0.55) CA12CA1CA2CA7CA9
SCHEMBL306569 0.75 CA12 (0.50) CA12CA1CA2CA7CA9
SCHEMBL29577150 0.75 LMNA (0.50) CA12CA1CA2CA7CA9
SCHEMBL9870996 0.74 KDM4E (0.58) ALDH1A1HPGDHSD17B10CYP1A2ADORA3
SCHEMBL14352130 0.74 ALDH1A1 (0.59) CA12CA1CA2CA7CA9
SCHEMBL8548096 0.74 ADORA3 (0.58) ALDH1A1HPGDHSD17B10CYP1A2ADORA3
SCHEMBL9308847 0.74 BRD4 (0.50) CA12CA1CA2CA7CA9
SCHEMBL17874238 0.74 CA12 (0.62) CA12CA1CA2CA7CA9
SCHEMBL27185753 0.74 CA12 (0.49) CA12CA1CA2CA7CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2611806-A1 DEUTERIUM-ENRICHED HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS Ascepion Pharmaceuticals, Inc. (CN) 2013-07-10 EP disclosed
WO-2012028106-A1 DEUTERIUM-ENRICHED HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS ASCEPION PHARMACEUTICALS, INC. (CN) 2012-03-08 WO disclosed